EORTC的小细胞肺癌试验。

European journal of respiratory diseases. Supplement Pub Date : 1987-01-01

N van Zandwijk, J G McVie, O Dalesio, A Kirkpatrick

{"title":"EORTC的小细胞肺癌试验。","authors":"N van Zandwijk, J G McVie, O Dalesio, A Kirkpatrick","doi":"","DOIUrl":null,"url":null,"abstract":"An overview of activities of the EORTC Lung Cancer Coöperative Group in small cell lung cancer is given. Optimal length of therapy, identification of patients with good/bad prognostic factors, role of surgery and the study of new drugs presently are the main areas of interest for the group. With its large patient potential the group is able to verify \"early favourable reports\" and to quickly perform phase II studies.","PeriodicalId":12048,"journal":{"name":"European journal of respiratory diseases. Supplement","volume":"149 ","pages":"57-62"},"PeriodicalIF":0.0000,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Small cell lung cancer trials in the EORTC.\",\"authors\":\"N van Zandwijk, J G McVie, O Dalesio, A Kirkpatrick\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"An overview of activities of the EORTC Lung Cancer Coöperative Group in small cell lung cancer is given. Optimal length of therapy, identification of patients with good/bad prognostic factors, role of surgery and the study of new drugs presently are the main areas of interest for the group. With its large patient potential the group is able to verify \\\"early favourable reports\\\" and to quickly perform phase II studies.\",\"PeriodicalId\":12048,\"journal\":{\"name\":\"European journal of respiratory diseases. Supplement\",\"volume\":\"149 \",\"pages\":\"57-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1987-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of respiratory diseases. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of respiratory diseases. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

综述了EORTC肺癌Coöperative组在小细胞肺癌中的活动。最佳治疗时间、患者预后因素的确定、手术的作用和新药的研究目前是该小组感兴趣的主要领域。凭借其巨大的患者潜力，该小组能够验证“早期有利报告”并迅速进行II期研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Small cell lung cancer trials in the EORTC.

An overview of activities of the EORTC Lung Cancer Coöperative Group in small cell lung cancer is given. Optimal length of therapy, identification of patients with good/bad prognostic factors, role of surgery and the study of new drugs presently are the main areas of interest for the group. With its large patient potential the group is able to verify "early favourable reports" and to quickly perform phase II studies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European journal of respiratory diseases. Supplement

自引率

0.00%

发文量

期刊最新文献

Small cell lung cancer. Small cell lung cancer. Monoclonal antibodies in lung cancer pathology. The rôle of proteases and antiproteases in bronchial secretions. Adverse effects of toxins and drugs on the surfactant systems.